Josep Marés

Immunogenicity and Safety of H5N1 A/Vietnam/1194/2004 (Clade 1) AS03-Adjuvanted Prepandemic Candidate Influenza Vaccines in Children Aged 3 to 9 Years

Javier Díez‐Domingo, María Garcés‐Sánchez, José‐María Baldó et al. · The Pediatric Infectious Disease Journal · 2010 · 75 citations · Full text

Microbiology of bacteria causing recurrent acute otitis media (AOM) and AOM treatment failure in young children in Spain: Shifting pathogens in the post-pneumococcal conjugate vaccination era

Félix Pumarola, Josep Marés, Isabel Losada et al. · International Journal of Pediatric Otorhinolaryngology · 2013 · 72 citations

Vaccination, Medical Microbiology, Microbial Disease +9

Immunogenicity and Reactogenicity of a Three-Dose Primary Vaccination Course With a Combined Diphtheria-Tetanus-Acellular Pertussis-Hepatitis B-Inactivated Polio-Haemophilus influenzae Type b Vaccine Coadministered With a Meningococcal C Conjugate Vaccine

Juan Carlos Tejedor Torres, Félix Omeñaca, José García-Sicilia et al. · The Pediatric Infectious Disease Journal · 2004 · 41 citations

Vaccination, Vaccine Safety, Vaccinology +15

Phase <scp>II</scp>, randomized, open, controlled study of <scp>AS</scp>03‐adjuvanted H5N1 pre‐pandemic influenza vaccine in children aged 3 to 9 years: follow‐up of safety and immunogenicity persistence at 24 months post‐vaccination

Javier Díez‐Domingo, José‐María Baldó, Maria Victoria Planelles‐Catarino et al. · Influenza and Other Respiratory Viruses · 2015 · 18 citations · Full text

Long-term (5-year) antibody persistence following two- and three-dose regimens of a combined hepatitis A and B vaccine in children aged 1–11 years

Helen Marshall, Terry Nolan, Javier Díez‐Domingo et al. · Vaccine · 2010 · 12 citations

Vaccination, Vaccinology, Infectious Disease Prevention +14